UltraGreen.ai Limited (SGX:ULG)

Singapore · Delayed Price · Currency is SGD · Price in USD

1.250

-0.020 (-1.57%)

At close: Jun 30, 2026

-17.22% (1Y)

Market Cap	1.78B
Revenue (ttm)	177.43M +91.5%
Net Income	97.27M +129.0%
EPS	0.25 -99.7%
Shares Out	1.10B
PE Ratio	9.51
Forward PE	16.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	571,700
Open	1.270
Previous Close	1.270
Day's Range	1.240 - 1.270
52-Week Range	1.180 - 1.860
Beta	n/a
Analysts	Strong Buy
Price Target	1.98 (+58.4%)
Earnings Date	Aug 4, 2026

About UltraGreen.ai

UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related t... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2024

Employees 101

Stock Exchange Singapore Exchange

Ticker Symbol ULG

Full Company Profile

Financial Performance

In 2025, UltraGreen.ai's revenue was $137.94 million, an increase of 27.70% compared to the previous year's $108.02 million. Earnings were $75.63 million, an increase of 35.15%.

Financial numbers in USD Financial Statements

Analyst Summary

According to 3 analysts, the average rating for ULG stock is "Strong Buy." The 12-month stock price target is $1.98, which is an increase of 58.40% from the latest price.

Price Target

$1.98

(58.40% upside)

Analyst Consensus: Strong Buy

Stock Forecasts